RHINETON Tablet Ref.[51191] Active ingredients: Chlorphenamine

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2023  Publisher: RANBAXY PHARMACEUTICALS (PTY) LTD., 14 LAUTRE ROAD, STORMILL EXT.1, ROODEPOORT 1724, SOUTH AFRICA

5.1. Pharmacodynamic properties

Category and class: A.5.7.1. Antihistaminics
Pharmacotherapeutic group: Antihistamines for systemic use
ATC code: R06AB02

RHINETON tablets contain the antihistamine, chlorpheniramine maleate. RHINETON competes reversibly with histamine for H1 receptor sites on effector cells. They suppress those symptoms due to histamine release. Antihistamines have anticholinergic properties and have a drying effect on the nasal mucosa.

5.2. Pharmacokinetic properties

Chlorpheniramine is well absorbed from the gastro-intestinal tract, following oral administration. The effects develop within 30 minutes, are maximal within 1 to 2 hours and last 4 to 6 hours. The plasma half-life has been estimated to be 12 to 15 hours.

Chlorpheniramine is metabolised to the monodesmethyl and didesmethyl derivatives. About 22% of an oral dose is excreted unchanged in the urine.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.